RELAY THERAPEUTICS

relay-therapeutics-logo

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

#People #Financial #Event #Website #More

RELAY THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2016-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.relaytx.com

Total Employee:
101+

Status:
Active

Contact:
(617)370-8837

Email Addresses:
[email protected]

Total Funding:
870 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress



Current Advisors List

kanishka-pothula_image

Kanishka Pothula Board Member @ Relay Therapeutics
Board_member

mark-murcko_image

Mark Murcko Board of Directors @ Relay Therapeutics
Board_member
2016-02-01

krishna-yeshwant_image

Krishna Yeshwant Board Member @ Relay Therapeutics
Board_member

mark-murcko_image

Mark Murcko Member of the Board of Directors @ Relay Therapeutics
Board_member
2016-02-01

matthew-jacobson_image

Matthew Jacobson Co-Founder @ Relay Therapeutics
Advisor

laura-shawver_image

Laura Shawver Member Board Of Directors @ Relay Therapeutics
Board_member
2017-03-01

Current Employees Featured

sanjiv-patel_image

Sanjiv Patel
Sanjiv Patel President & CEO @ Relay Therapeutics
President & CEO
2017-03-01

mark-murcko_image

Mark Murcko
Mark Murcko Founder @ Relay Therapeutics
Founder
2016-02-01

patrick-walters_image

Patrick Walters
Patrick Walters SVP of Computation @ Relay Therapeutics
SVP of Computation

not_available_image

Donald A. Bergstrom
Donald A. Bergstrom President of Research and Development @ Relay Therapeutics
President of Research and Development
2018-04-01

iain-martin_image

Iain Martin
Iain Martin Vice President, Drug Metabolism and Pharmacokinetics @ Relay Therapeutics
Vice President, Drug Metabolism and Pharmacokinetics
2019-07-01

patrick-riley_image

Patrick Riley
Patrick Riley SVP, AI @ Relay Therapeutics
SVP, AI
2021-05-01

imogen-pryce_image

Imogen Pryce
Imogen Pryce Chief Operating Officer, R&D @ Relay Therapeutics
Chief Operating Officer, R&D
2022-01-01

mary-mader_image

Mary Mader
Mary Mader Vice President, Chemistry @ Relay Therapeutics
Vice President, Chemistry
2018-11-01

george-voren_image

George Voren
George Voren Associate Director @ Relay Therapeutics
Associate Director
2019-06-01

mahesh-padval_image

Mahesh Padval
Mahesh Padval SVP of Pharmaceutical Drug Development @ Relay Therapeutics
SVP of Pharmaceutical Drug Development

Founder


david-e-shaw_image

David E. Shaw

dorothee-kern_image

Dorothee Kern

mark-murcko_image

Mark Murcko

matthew-jacobson_image

Matthew Jacobson

Stock Details


Company's stock symbol is NASDAQ:RLAY

Acquisitions List

Date Company Article Price
2021-04-16 ZebiAI ZebiAI acquired by Relay Therapeutics 85 M USD

Investors List

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series C - Relay Therapeutics

tavistock-group_image

Tavistock Group

Tavistock Group investment in Series C - Relay Therapeutics

softbank-vision-fund_image

SoftBank Vision Fund

SoftBank Vision Fund investment in Series C - Relay Therapeutics

alexandria-venture_image

Alexandria Venture

Alexandria Venture investment in Series C - Relay Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Relay Therapeutics

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series C - Relay Therapeutics

d-e-shaw-research_image

D. E. Shaw Research

D. E. Shaw Research investment in Series C - Relay Therapeutics

google-ventures_image

GV

GV investment in Series C - Relay Therapeutics

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series C - Relay Therapeutics

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Series C - Relay Therapeutics

Key Employee Changes

Date New article
2021-05-14 Relay Therapeutics adds artificial intelligence exec

Official Site Inspections

http://www.relaytx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.23 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Relay Therapeutics" on Search Engine